We are live on ! Find out more
ONCO icon

Onconetix
ONCO

9 hedge funds and large institutions have $492K invested in Onconetix in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

50% more funds holding

Funds holding: 6 → 9 (+3)

18% more capital invested

Capital invested by funds: $417K → $492K (+$74.6K)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
9
Holders Change
+3
Holders Change %
+50%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Zurich Cantonal Bank
Zurich Cantonal Bank
Switzerland
+$50.8K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$25.4K
3
HF
HRT Financial
New York
+$25.4K
4
Jane Street
Jane Street
New York
+$25.4K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$25.4K

Top Sellers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
-$17.5K
2
VF
Virtu Financial
New York
-$4K
3
UBS Group
UBS Group
Switzerland
-$554
4
Wells Fargo
Wells Fargo
California
-$20

ONCO Hedge Fund Activity: Q2 2024 in Review

9 of the 6,934 institutional investors tracked by Wall St. Rank reported a position in Onconetix (ONCO) for Q2 2024, worth a combined $492K — up 18% from $417K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ONCO positions and 1 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Zurich Cantonal Bank, opening a new position worth an estimated $50.8K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $17.5K sold.

  • 9 institutional investors held Onconetix (ONCO) as of Q2 2024, up from 6 in Q1 2024.
  • Funds reported $492K of Onconetix stock for Q2 2024, up 18% quarter-over-quarter.
  • 5 funds opened new Onconetix positions in Q2 2024 and 1 closed out, a net change of +4 holders.
  • The largest Onconetix buyer in Q2 2024 was Zurich Cantonal Bank, an estimated $50.8K added.
  • The largest Onconetix seller in Q2 2024 was Two Sigma Securities, an estimated $17.5K sold.

Based on aggregated 13F filings for Q2 2024.